Loading…
Lobbying Spend
$531K
Filings
87
Firms Hired
1
Active Period
2000–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Stem Cell Therapeutic and Research Reauthorization Act of 2025
2026 · first_quarter · Firm: AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES
Stem Cell Therapeutic and Research Reauthorization Act (SCTRRA) (S. 4109/H.R. 5160)
Client expense: — · Firm income: —
Matched citations: H.R. 5160
Stem Cell Therapeutic and Research Reauthorization Act of 2026
2026 · first_quarter · Firm: AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES
Stem Cell Therapeutic and Research Reauthorization Act (SCTRRA) (S. 4109/H.R. 5160)
Client expense: — · Firm income: —
Matched citations: S. 4109
PREVENT Pandemics Act
2022 · first_quarter · Firm: AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES
The "Prepare for and Respond to Existing Viruses, Emerging New Threats, and Pandemics Act" or the "PREVENT Pandemics Act" (S. 3799) on issues pertaining to the blood supply.
Client expense: — · Firm income: —
Matched citations: S. 3799
Improving Access to Transfusion Care for Hospice Patients Act of 2021
2021 · fourth_quarter · Firm: AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES
Improving Access to Transfusion Care for Hospice Patients Act of 2021 (S. 2566), and supporting a CMMI demonstration project that would establish a separate payment for blood transfusions furnished to patients receiving hospice care.
Client expense: — · Firm income: —
Matched citations: S. 2566
Improving Access to Transfusion Care for Hospice Patients Act of 2021
2021 · third_quarter · Firm: AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES
Improving Access to Transfusion Care for Hospice Patients Act of 2021 (S. 2566), and supporting a CMMI demonstration project that would establish a separate payment for blood transfusions furnished to patients receiving hospice care. Supporting a bill that would authorize the Centers for Medicare and Medicaid Services (CMS) to develop a program for Medicaid beneficiaries to improve access to comprehensive outpatient care for individuals with sickle cell disease.
Client expense: — · Firm income: —
Matched citations: S. 2566
CARES Act
2020 · first_quarter · Firm: AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES
Coronavirus Aid, Relief, and Economic Security Act (H.R. 748) on issues pertaining to the blood supply.
Client expense: — · Firm income: —
Matched citations: H.R. 748
PACT Act
2019 · fourth_quarter · Firm: AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES
Support for the Patient Access to Cellular Transplant (PACT) Act (S. 1286/H.R. 2498).
Client expense: — · Firm income: —
Matched citations: H.R. 2498
Energy Technology Maturation Act of 2019
2019 · fourth_quarter · Firm: AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES
Support for the Patient Access to Cellular Transplant (PACT) Act (S. 1286/H.R. 2498).
Client expense: — · Firm income: —
Matched citations: S. 1286
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019
2019 · first_quarter · Firm: AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES
Request that the Senate advance the Pandemic and All-Hazards Preparedness Advancing Innovation Act (PAHPAI, H.R. 269).
Client expense: — · Firm income: —
Matched citations: H.R. 269
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
2018 · fourth_quarter · Firm: AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES
The Pandemic and All-Hazards Preparedness Advancing Innovation Act (S. 2852/H.R. 6378), which includes requirements that (1) the Assistant Secretary for Preparedness and Response consult with stakeholders to develop guidelines for regional public health emergency preparedness and response systems and (2) the Department of Health and Human Services submit a report to Congress containing recommendations related to maintaining an adequate national blood supply.
Client expense: — · Firm income: —
Matched citations: H.R. 6378
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
2018 · fourth_quarter · Firm: AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES
The Pandemic and All-Hazards Preparedness Advancing Innovation Act (S. 2852/H.R. 6378), which includes requirements that (1) the Assistant Secretary for Preparedness and Response consult with stakeholders to develop guidelines for regional public health emergency preparedness and response systems and (2) the Department of Health and Human Services submit a report to Congress containing recommendations related to maintaining an adequate national blood supply.
Client expense: — · Firm income: —
Matched citations: S. 2852
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
2018 · third_quarter · Firm: AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES
The Pandemic and All-Hazards Preparedness Advancing Innovation Act (S. 2852/H.R. 6378), which includes requirements that (1) the Assistant Secretary for Preparedness and Response consult with stakeholders to develop guidelines for regional public health emergency preparedness and response systems and (2) the Department of Health and Human Services submit a report to Congress containing recommendations related to maintaining an adequate national blood supply.
Client expense: — · Firm income: —
Matched citations: H.R. 6378
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
2018 · third_quarter · Firm: AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES
The Pandemic and All-Hazards Preparedness Advancing Innovation Act (S. 2852/H.R. 6378), which includes requirements that (1) the Assistant Secretary for Preparedness and Response consult with stakeholders to develop guidelines for regional public health emergency preparedness and response systems and (2) the Department of Health and Human Services submit a report to Congress containing recommendations related to maintaining an adequate national blood supply.
Client expense: — · Firm income: —
Matched citations: S. 2852
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
2018 · second_quarter · Firm: AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES
S. 2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 and House bill reauthorizing the Pandemic and All-Hazards Preparedness Act.
Client expense: — · Firm income: —
Matched citations: S. 2852
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017
2018 · first_quarter · Firm: AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES
Sickle Cell Disease Surveillance, Prevention, and Treatment Act of 2018 (H.R. 2410/ S. 2465), which would reauthorize a sickle cell disease prevention and treatment demonstration program and provide for sickle cell disease research, surveillance, prevention, and treatment.
Client expense: — · Firm income: —
Matched citations: H.R. 2410
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017
2018 · first_quarter · Firm: AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES
Sickle Cell Disease Surveillance, Prevention, and Treatment Act of 2018 (H.R. 2410/ S. 2465), which would reauthorize a sickle cell disease prevention and treatment demonstration program and provide for sickle cell disease research, surveillance, prevention, and treatment.
Client expense: — · Firm income: —
Matched citations: H.R. 2410
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018
2018 · first_quarter · Firm: AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES
Sickle Cell Disease Surveillance, Prevention, and Treatment Act of 2018 (H.R. 2410/ S. 2465), which would reauthorize a sickle cell disease prevention and treatment demonstration program and provide for sickle cell disease research, surveillance, prevention, and treatment.
Client expense: — · Firm income: —
Matched citations: S. 2465
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018
2018 · first_quarter · Firm: AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES
Sickle Cell Disease Surveillance, Prevention, and Treatment Act of 2018 (H.R. 2410/ S. 2465), which would reauthorize a sickle cell disease prevention and treatment demonstration program and provide for sickle cell disease research, surveillance, prevention, and treatment.
Client expense: — · Firm income: —
Matched citations: S. 2465
To amend title XVIII of the Social Security Act to ensure that providers of services receive adequate payments for the acquisition of hematopoietic stem cells under the Medicare program, and for other purposes.
2017 · fourth_quarter · Firm: AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES
H.R. 4215 (Protect Access to Cellular Transplant (PACT) Act), which would require Medicare to make separate payments to hospitals to cover costs associated with donor search and acquisition for hematopoietic cell transplantation.
Client expense: — · Firm income: —
Matched citations: H.R. 4215
To amend title XVIII of the Social Security Act to ensure that providers of services receive adequate payments for the acquisition of hematopoietic stem cells under the Medicare program, and for other purposes.
2017 · fourth_quarter · Firm: AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES
H.R. 4215 (Protect Access to Cellular Transplant (PACT) Act), which would require Medicare to make separate payments to hospitals to cover costs associated with donor search and acquisition for hematopoietic cell transplantation.
Client expense: — · Firm income: —
Matched citations: H.R. 4215
Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act
2016 · fourth_quarter · Firm: AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES
Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act, H.R. 5325 Cost-recovery regarding implementation of guidance issued by the Food and Drug Administration entitled, "Revised Recommendations for Reducing the Risk of Zika Virus Transmission by Blood and Blood Components"
Client expense: — · Firm income: —
Matched citations: H.R. 5325
Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act
2016 · fourth_quarter · Firm: AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES
Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act, H.R. 5325 Cost-recovery regarding implementation of guidance issued by the Food and Drug Administration entitled, "Revised Recommendations for Reducing the Risk of Zika Virus Transmission by Blood and Blood Components"
Client expense: — · Firm income: —
Matched citations: H.R. 5325
Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act
2016 · fourth_quarter · Firm: AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES
Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act, H.R. 5325 Cost-recovery regarding implementation of guidance issued by the Food and Drug Administration entitled, "Revised Recommendations for Reducing the Risk of Zika Virus Transmission by Blood and Blood Components"
Client expense: — · Firm income: —
Matched citations: H.R. 5325
Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act
2016 · third_quarter · Firm: AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES
Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act, H.R. 5325 Cost-recovery regarding implementation of guidance issued by the Food and Drug Administration entitled, "Revised Recommendations for Reducing the Risk of Zika Virus Transmission by Blood and Blood Components"
Client expense: — · Firm income: —
Matched citations: H.R. 5325
Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act
2016 · third_quarter · Firm: AMERICAN ASSOCIATION OF BLOOD BANKS, DBA ASSOCIATION FOR THE ADVANCEMENT OF BLOOD & BIOTHERAPIES
Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act, H.R. 5325 Cost-recovery regarding implementation of guidance issued by the Food and Drug Administration entitled, "Revised Recommendations for Reducing the Risk of Zika Virus Transmission by Blood and Blood Components"
Client expense: — · Firm income: —
Matched citations: H.R. 5325
Source: Senate LDA